Medical peeps - isn't tocilizumab similarly constructed to Sarilumab, who's severe phase 3 trial was just halted due to failure to meet primary & secondary endpoints? If so, I doubt the feds would start touting that right now.

Quote:

---

I continue to think tocilizumab (actemra) is a candidate for this week's government announcement, even though their prior results weren't great.

Last week, a 450 person Phase III tocilizumab trial changed status from "recruiting" to "active, not recruiting" on clinicaltrials.gov.

Read More: https://investorshangout.com/post/view?id=581...z6RREHpw00

---